Path Vaccine Solutions
Seattle, Washington · EIN 830431851 · Private foundation
Path Vaccine Solutions is a private foundation based in Seattle, Washington. Its most recent IRS Form 990-PF reports $4.8M in grants paid and $0 in total assets. Bespoke Grants tracks 29 individual grants from this funder — $32.9M awarded across 2017–2020 — including its support for public health. Below is its full funding profile.
What Path Vaccine Solutions funds
Path Vaccine Solutions's giving carries a documented focus on public health, scientific research.
Populations it has supported include children, low-income communities.
Grant history
The largest grants Bespoke Grants has on record for Path Vaccine Solutions, by amount:
| Recipient | Location | Grant | Year |
|---|---|---|---|
| Path PRODUCT DEVELOPMENT | Seattle, WA | $15.3M | 2017 |
| Path ESSENTIAL MEDICINE | Seattle, WA | $4.4M | 2020 |
| Path ESSENTIAL MEDICINE | Seattle, WA | $4.3M | 2019 |
| Infectious Disease Research Institute PRODUCT DEVELOPMENT | Seattle, WA | $1.3M | 2017 |
| Advanced Bioscience Laboratories Inc PRODUCT DEVELOPMENT | Rockville, MD | $1.1M | 2017 |
| Cincinnati Children's Hospital Medical Center PRODUCT DEVELOPMENT | Cincinnati, OH | $882K | 2017 |
| University of Maryland School of Medicine Center for Vaccine Development PRODUCT DEVELOPMENT | Baltimore, MD | $873K | 2017 |
| United States Naval Medical Research Center PRODUCT DEVELOPMENT | Silver Spring, MD | $859K | 2017 |
| Walter Reed Army Institute of Research PRODUCT DEVELOPMENT | Silver Spring, MD | $591K | 2017 |
| Henry M Jackson Foundation for the Advancement of Military Medicine PRODUCT DEVELOPMENT | Bethesda, MD | $497K | 2017 |
| Boston Children's Hospital PRODUCT DEVELOPMENT | Boston, MA | $340K | 2017 |
| Johns Hopkins University PRODUCT DEVELOPMENT | Baltimore, MD | $326K | 2017 |
| University of Maryland Baltimore PRODUCT DEVELOPMENT | Baltimore, MD | $265K | 2017 |
| Immport Therapeutics Inc PRODUCT DEVELOPMENT | Irvine, CA | $235K | 2017 |
| Jhu Bloomberg School of Public Health PRODUCT DEVELOPMENT | Baltimore, MD | $226K | 2017 |
Path Vaccine Solutions giving by year
Total grants Bespoke Grants has indexed for each filing year:
How to apply for funding from Path Vaccine Solutions
Path Vaccine Solutions's public IRS filing does not spell out a formal application process. Foundations of this size often give primarily to organizations they already know, so a concise letter of inquiry or a warm introduction is usually the best first contact — not a full proposal.
Is Path Vaccine Solutions the right funder for your nonprofit?
This page shows what Path Vaccine Solutions has funded. Bespoke Grants tells you whether it fits your mission — and finds every other foundation that does. Free, no credit card.
Match my nonprofit to funders →Frequently asked questions about Path Vaccine Solutions
- Does Path Vaccine Solutions accept grant applications?
- Path Vaccine Solutions's public filing does not specify an application process. A brief letter of inquiry or a warm introduction is usually the best first step with a private foundation of this size.
- What does Path Vaccine Solutions fund?
- Path Vaccine Solutions's grants focus on public health. Recent recipients include Path, Path, Path. Its full grant history is listed above.
- How much does Path Vaccine Solutions give in grants?
- Path Vaccine Solutions reported $4.8M in grants in its most recent IRS filing (FY2020). Across all years in our data it has awarded $32.9M over 29 grants.
- Where is Path Vaccine Solutions located?
- Path Vaccine Solutions is based in Seattle, Washington. Its IRS employer identification number (EIN) is 830431851.
- How can I find foundations similar to Path Vaccine Solutions?
- Bespoke Grants matches your nonprofit against 225,000+ foundations like Path Vaccine Solutions, ranking each by how well it fits your mission, location, and budget — with the reasoning shown. It is free to search.
Find more funders like Path Vaccine Solutions
Foundations similar to Path Vaccine Solutions
Other Washington grantmakers with overlapping priorities: